Literature DB >> 14264029

RETROPERITONEAL GERMINOMAS (SEMINOMAS) WITHOUT EVIDENCE OF TESTICULAR INVOLVEMENT.

M R ABELL, J V FAYOS, I LAMPE.   

Abstract

Keywords:  DISGERMINOMA; PATHOLOGY; RETROPERITONEAL NEOPLASMS

Mesh:

Year:  1965        PMID: 14264029     DOI: 10.1002/1097-0142(196503)18:3<273::aid-cncr2820180304>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  8 in total

1.  Extragonadal germ cell tumours.

Authors:  M Hornák; D Ondrus
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

2.  Specialized intercellular junctions in human intracranial germinomas.

Authors:  E Tani; K Ikeda; S Kudo; S Yamagata; M Nishiura
Journal:  Acta Neuropathol       Date:  1974-02-28       Impact factor: 17.088

3.  [Cerebral metastases from an ectopic chorionepithelioma in man. A contribution to the differential diagnosis of intracerebral hemorrhage (author's transl)].

Authors:  H Collmann; J Wiesener; H Grauthoff
Journal:  J Neurol       Date:  1974       Impact factor: 4.849

4.  Extragonadal sacrococcygeal seminoma--a case report.

Authors:  H Iwagaki; S Fuchimoto; S Yunoki; Y Higuchi; S Akagi; K Orita
Journal:  Jpn J Surg       Date:  1990-03

5.  Primary retroperitoneal seminoma: an unusual cause of testicular pain.

Authors:  Sachin Malde
Journal:  JRSM Short Rep       Date:  2010-12-20

6.  Burned-out testicular tumor: a case report.

Authors:  N Balalaa; M Selman; W Hassen
Journal:  Case Rep Oncol       Date:  2011-01-15

7.  Unusual lump in the groin.

Authors:  F D Beggs
Journal:  J R Soc Med       Date:  1983-03       Impact factor: 18.000

8.  Successful treatment of a high-risk nonseminomatous germ cell tumor using etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine: A case report.

Authors:  Jina Yun; Sang W Lee; Sung H Lim; Se H Kim; Chan K Kim; Seong K Park
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.